サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375074

アジア太平洋の心臓マイクロカテーテル市場の2028年までの予測-地域別分析-適応症別、エンドユーザー別

Asia Pacific Cardiac Microcatheter Market Forecast to 2028- COVID-19 Impact and Regional Analysis- by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)
出版日: | 発行: The Insight Partners | ページ情報: 英文 116 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
アジア太平洋の心臓マイクロカテーテル市場の2028年までの予測-地域別分析-適応症別、エンドユーザー別
出版日: 2023年08月21日
発行: The Insight Partners
ページ情報: 英文 116 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の心臓マイクロカテーテル市場は、2023年の8,047万米ドルから2028年には1億1,476万米ドルに成長すると予測されています。2023年から2028年までのCAGRは7.4％と推定されています。

新製品承認、上市、心臓マイクロカテーテル分野の認知度がアジア太平洋心臓マイクロカテーテル市場を後押し

冠動脈インターベンションツールとして、マイクロカテーテルは複雑な血管解剖学において幅広い機能を果たすことで、侵襲的な血管内治療の実施をサポートします。世界中のメーカーが先端技術の研究開発に投資しており、その結果、製品承認の急増とともに、新しく先進的な製品が開発されています。いくつかの製品承認と開発を以下に示す;2019年、iVascularの新しい冠動脈マイクロカテーテルであるNavitianがCEマーク承認を取得しました。このデバイスは、冠動脈系へのアクセス、ガイドワイヤーの交換、放射線不透過性造影剤または生理食塩水の注入の際に、ガイドワイヤーを促進、誘導、支持することが承認されました。2020年、BraccoグループのAcist Medical Systems Inc.は、Acist RXi Rapid Exchange FFRシステムで使用する第2世代のマイクロカテーテルであるAcist Navvus II Rapid Exchange fractional flow reserve（FFR）マイクロカテーテルの世界の発売を発表しました。FFR測定は、冠動脈疾患の診断と治療において、動脈病変の重症度と介入戦略を評価します。2023年5月、Acotec Scientific Holdings Ltd.は、経皮的冠動脈インターベンションおよび経皮的末梢インターベンションを支援するマイクロカテーテルVericor-14の中国での販売承認を取得し、10年末までに8倍に成長すると予測される競争市場で一歩先んじた。

したがって、新製品の承認、発売、心臓マイクロカテーテル分野における認知度の急上昇が、予測期間中の心臓マイクロカテーテル市場の成長を促進すると予想されます。

アジア太平洋の心臓マイクロカテーテル市場概要

アジア太平洋地域の心臓マイクロカテーテル市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。アジア太平洋地域は心臓マイクロカテーテル市場で重要な位置を占めており、予測期間中に有望な成長軌道を示すと期待されています。市場成長の原動力は、心血管疾患の有病率の増加、高齢化人口の増加、ヘルスケアインフラの改善、低侵襲手技に対する意識の高まりです。

アジア太平洋の心臓マイクロカテーテル市場の収益と2028年までの予測（金額）

アジア太平洋の心臓マイクロカテーテル市場のセグメンテーション

アジア太平洋の心臓マイクロカテーテル市場は、適応症、エンドユーザー、国別に区分されます。

適応症に基づいて、アジア太平洋の心臓マイクロカテーテル市場は一般末梢血管と冠状動脈にセグメント化されます。2023年のアジア太平洋心臓マイクロカテーテル市場では、冠動脈セグメントのシェアが大きいです。

エンドユーザーに基づくと、アジア太平洋の心臓マイクロカテーテル市場は病院、専門クリニック、外来手術センターに区分されます。2023年のアジア太平洋心臓マイクロカテーテル市場では、病院セグメントが最大のシェアを占めています。

国別では、アジア太平洋心臓マイクロカテーテル市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。中国が2023年のアジア太平洋心臓マイクロカテーテル市場のシェアを独占。

Boston Scientific Corp;Integer Holdings Corp;Medtronic Plc;Merit Medical Systems Inc;Nipro Corp;OrbusNeich Medical Group Holdings Ltd;Teleflex Inc;Terumo Corp;and Tokai Medical Products Incがアジア太平洋心臓マイクロカテーテル市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 アジア太平洋の心臓マイクロカテーテル市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の心臓マイクロカテーテル市場- 市場情勢

  • アジア太平洋地域のPEST分析
  • 専門家の見解

第5章 アジア太平洋の心臓マイクロカテーテル市場-主要市場力学

  • 市場促進要因
    • 心血管疾患の有病率の増加
    • 慢性全閉塞（CTO）治療のための経皮的冠動脈インターベンション（PCI）使用の増加
  • 市場抑制要因
    • 心臓マイクロカテーテルの使用に関連する合併症と故障
  • 市場機会
    • ヘルスケア支出の増加と心臓の健康に関する政府主導の取り組み
  • 今後の動向
    • 心臓マイクロカテーテル分野における新製品の承認、上市、認知度の急上昇
  • 促進要因と抑制要因の影響分析

第6章 アジア太平洋の心臓マイクロカテーテル市場の分析

  • アジア太平洋の心臓マイクロカテーテル市場収益と予測分析

第7章 アジア太平洋の心臓マイクロカテーテル市場-2028年までの収益と予測-適応症別

  • 冠動脈
  • 一般末梢血管

第8章 アジア太平洋地域の心臓マイクロカテーテル市場分析-エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック

第9章 アジア太平洋地域の心臓マイクロカテーテル市場-2028年までの収益と予測-：国別分析

第10章 アジア太平洋地域の心臓マイクロカテーテル市場：業界情勢

  • 有機的展開

第11章 企業プロファイル

  • Boston Scientific Corp
  • Teleflex Inc
  • Medtronic Plc
  • OrbusNeich Medical Group Holdings Ltd
  • Merit Medical Systems Inc
  • Nipro Corp
  • Terumo Corp
  • Tokai Medical Products Inc
  • Integer Holdings Corp

第12章 付録

図表

List Of Tables

  • Table 1. China: Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. China: Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Japan: Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Japan: Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. India: Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. India: Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Australia: Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Australia: Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. South Korea: Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. South Korea: Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Rest of Asia Pacific: Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Rest of Asia Pacific: Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Organic Developments Done by Companies
  • Table 14. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Cardiac Microcatheter Market Segmentation
  • Figure 2. Asia Pacific Cardiac Microcatheter Market by Country
  • Figure 3. Asia Pacific Cardiac Microcatheter Market Overview
  • Figure 4. Coronary Held Largest Share of Indication Segment in Asia Pacific Cardiac Microcatheter Market
  • Figure 5. Asia Pacific Cardiac Microcatheter Market - Leading Country Markets (US$ Million)
  • Figure 6. Asia Pacific PEST Analysis
  • Figure 7. Asia Pacific Cardiac Microcatheter Market Impact Analysis of Drivers and Restraints
  • Figure 8. Asia Pacific Cardiac Microcatheter Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 9. Asia Pacific Cardiac Microcatheter Market Revenue Share, by Indication, 2022 & 2028 (%)
  • Figure 10. Coronary: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. General Peripheral Vascular: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Asia Pacific Cardiac Microcatheter Market Revenue Share, by End User, 2022 & 2028 (%)
  • Figure 13. Hospitals: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Ambulatory Surgical Centers: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Specialty Clinics: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Asia Pacific Cardiac Microcatheter Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 17. China: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Japan: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. India: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Australia: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. South Korea: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Rest of Asia Pacific: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028749

The Asia Pacific cardiac microcatheter market is expected to grow from US$ 80.47 million in 2023 to US$ 114.76 million by 2028. It is estimated to grow at a CAGR of 7.4% from 2023 to 2028.

Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter Fuel Asia Pacific Cardiac Microcatheter Market

As a coronary interventional tool, microcatheters support the performance of invasive endovascular procedures by fulfilling a wide range of functions in complex vascular anatomies. Manufacturers across the world are investing in research and development of advanced technologies, which has led to the development of new and advanced products, along with a surge in product approvals. A few product approvals and developments are listed below ; In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions. In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements assess arterial lesion severity and the intervention strategies in diagnosing and treating coronary artery disease. In May 2023, Acotec Scientific Holdings Ltd. received Chinese marketing approval for its microcatheter Vericor-14 to assist in percutaneous coronary interventions and percutaneous peripheral interventions, taking a step ahead in a competitive market that is poised to grow eightfold by the end of the decade.

Therefore, a surge in new product approvals, launches, and awareness in the field of cardiac microcatheter is expected to fuel the cardiac microcatheter market growth during the forecast period.

Asia Pacific Cardiac Microcatheter Market Overview

The Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region occupies a significant position in the Asia Pacific cardiac microcatheter market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures.

Asia Pacific Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Cardiac Microcatheter Market Segmentation

The Asia Pacific cardiac microcatheter market is segmented into indication, end user, and country.

Based on indication, the Asia Pacific cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the Asia Pacific cardiac microcatheter market in 2023.

Based on end user, the Asia Pacific cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the Asia Pacific cardiac microcatheter market in 2023.

Based on country, the Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the share of the Asia Pacific cardiac microcatheter market in 2023.

Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; OrbusNeich Medical Group Holdings Ltd; Teleflex Inc; Terumo Corp; and Tokai Medical Products Inc are the leading companies operating in the Asia Pacific cardiac microcatheter market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific cardiac microcatheter market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific cardiac microcatheter market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Cardiac Microcatheter Market - by Indication
    • 1.3.2 Asia Pacific Cardiac Microcatheter Market - by End User
    • 1.3.3 Asia Pacific Cardiac Microcatheter Market - by Country

2. Asia Pacific Cardiac Microcatheter Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Cardiac Microcatheter Market - Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis
  • 4.3 Experts' Opinion

5. Asia Pacific Cardiac Microcatheter Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Cardiovascular Diseases
    • 5.1.2 Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO)
  • 5.2 Market Restraints
    • 5.2.1 Complications and Failures Related to Usage of Cardiac Microcatheter
  • 5.3 Market Opportunity
    • 5.3.1 Increasing Healthcare Spending and Government-led Initiatives Regarding Heart Health
  • 5.4 Future Trends
    • 5.4.1 Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter
  • 5.5 Impact Analysis of Drivers and Restraints

6. Cardiac Microcatheter Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Cardiac Microcatheter Market Revenue Forecast and Analysis

7. Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 - by Indication

  • 7.1 Overview
  • 7.2 Coronary
    • 7.2.1 Overview
    • 7.2.2 Coronary: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.3 General Peripheral Vascular
    • 7.3.1 Overview
    • 7.3.2 General Peripheral Vascular: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Cardiac Microcatheter Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Hospitals
    • 8.2.1 Overview
    • 8.2.2 Hospitals: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.3 Ambulatory Surgical Centers
    • 8.3.1 Overview
    • 8.3.2 Ambulatory Surgical Centers: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Specialty Clinics
    • 8.4.1 Overview
    • 8.4.2 Specialty Clinics: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 China: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 China: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.3 China: Asia Pacific Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.1.1.4 China: Asia Pacific Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.2 Japan: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Japan: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.3 Japan: Asia Pacific Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.1.2.4 Japan: Asia Pacific Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.3 India: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 India: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.3 India: Asia Pacific Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.1.3.4 India: Asia Pacific Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.4 \Australia: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Australia: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.4.3 Australia: Asia Pacific Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.1.4.4 Australia: Asia Pacific Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.5 South Korea: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 South Korea: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.5.3 South Korea: Asia Pacific Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.1.5.4 South Korea: Asia Pacific Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.6 Rest of Asia Pacific: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Asia Pacific: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.6.3 Rest of Asia Pacific: Asia Pacific Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.6.4 Rest of Asia Pacific: Asia Pacific Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Cardiac Microcatheter Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Organic Developments
    • 10.2.1 Overview

11. Company Profiles

  • 11.1 Boston Scientific Corp
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Teleflex Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Medtronic Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 OrbusNeich Medical Group Holdings Ltd
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Merit Medical Systems Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Nipro Corp
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Terumo Corp
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Tokai Medical Products Inc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Integer Holdings Corp
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms